CMS launches Open Payments search tool

Laura Pedulli | | Health Exec | Policy & Regulations

The Centers for Medicare & Medicaid Services (CMS) has released a beta search tool to help consumers better conduct searches of the Open Payments database, which contains information on physicians' corporate financial relationships.

In a CMS post, Shantanu Agrawal, MD, CMS deputy administrator and director of its Center for Program Integrity, requested feedback on the tool that now allows users to search for a doctor by name.

"Additional enhancements will be made available in coming weeks, including displays of summary data, data charts, graphs, as well as more detailed data. These innovative improvements will add value to both consumers and researchers using the Open Payments data," wrote Agrawal.

In addition, the agency is adding more granular information on the data released, including updating the data about the company that made the payment, according to Agrawal.

Access the data and new search tool here.

Laura Pedulli

Related Content

Mangione now faces federal charges, death penalty in murder of UHC CEO
FDA issues Class I recall on counterfeit infusion pump batteries
FDA issues alert on PCNL sheath safety after patient death
DOJ sues CVS over unlawful opioid prescriptions and reimbursement
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders
Advancing AI for vascular surgery will require a commitment to data integrity

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.